A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2009
12/23/2009	CN100572364C HIV replication inhibiting pyrimidines and triazines
12/23/2009	CN100571775C Avian influenza virus marking vaccine, preparation process and application thereof
12/23/2009	CN100571774C Typhoid, paratyphoid envelope protein vaccine
12/23/2009	CN100571763C Chinese-medicinal decoction for treating ribbon bleb
12/23/2009	CN100571756C Chinese traditional medicine composition for treating influenza and quality controlling method and detection method thereof
12/23/2009	CN100571742C Preparation method of medicinal composition for wind-cold
12/23/2009	CN100571723C Chinese medicine composition for treating urinary infection
12/23/2009	CN100571715C Compositions containing bioactive materials, methods of preparation and treatment
12/23/2009	CN100571713C Novel use of silver peroxide
12/23/2009	CN100571704C Fixed dose compound preparation of antitubercular drug and its preparing method
12/23/2009	CN100571702C Novel use of quinolone antibiotics
12/23/2009	CN100571681C Zedoary oil nano emulsion and its preparation process
12/23/2009	CN100571680C Preparation method of compound bitter sophora preparation for injection and medical use thereof
12/23/2009	CN100571525C Bamboo charcoal bag health-care tea
12/23/2009	CA2735724A1 Compositions and methods for treating influenza
12/23/2009	CA2728308A1 Compositions and methods of use of orf1358 from beta-hemolytic streptococcal strains
12/23/2009	CA2728258A1 Compositions and methods of use of orf 554 from beta hemolytic streptococcal strains
12/23/2009	CA2727362A1 New trinem antibiotics and inhibitors of beta-lactamases
12/23/2009	CA2726529A1 Use of zinc chelators to inhibit biofilm formation
12/23/2009	CA2724767A1 Synthetic analogues of phosphatidyl-myo-inositol mannosides with an inhibitory activity on the inflammatory response
12/22/2009	US7635774 Benzimidazole derivatives
12/22/2009	US7635769 Oligoribonucleotide derivatives for specific inhibition of gene expression
12/22/2009	US7635751 For development of pharmaceutical preparations such as neutral nerve function regulator, circulatory function regulator, a cardiac function regulator, an immune function regulator, a digestive organ function regulator, metabolic function regulator
12/22/2009	US7635704 Stable crystal of 4-oxoquinoline compound
12/22/2009	US7635688 Gene expression vectors; intensifier dor sequence determiantion; induce immunology response; viricides
12/22/2009	US7635681 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
12/22/2009	US7635556 Methods for drug discovery, disease treatment, and diagnosis using metabolomics
12/22/2009	US7635491 Method for administering selenium for treating patients suffering from systemic inflammatory response syndrome (SIRS), and composition for implementing the treatment
12/22/2009	US7635487 Nucleic acid molecules encoding a hyperimmune serum reactive antigen or a fragment thereof as well as hyperimmune serum reactive antigens or fragments thereof from S. pneumoniae; for prevention and treatment of bacterial infections caused by Streptococcus pneumoniae
12/22/2009	US7635486 Where lipidation thereof is from expression of first nucleic acid sequence and protein portion thereof is from expression of second nucleic acid sequence and first and second sequences do not naturally occur together, such as a lipoprotein where first sequence encodes Borrelia lipoprotein, second, PsaA
12/22/2009	US7635483 Enzymatically inactive streptococcal C5a peptidase (SCP) conjugated or linked to one or more peptides; effective in immunizing a susceptible mammal against beta-hemolytic Streptococcus
12/22/2009	US7635480 Peptides for preventing, diagnosing and treating animal and/or human leptospirosis
12/22/2009	US7635467 Mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
12/22/2009	CA2492954C Pegylated t1249 polypeptide
12/22/2009	CA2447166C Delivery of erectile dysfunction drugs through an inhalation route
12/22/2009	CA2446990C Delivery of sedative-hypnotics through an inhalation route
12/22/2009	CA2446917C Delivery of antipsychotics through an inhalation route
12/22/2009	CA2446916C Delivery of opioids through an inhalation route
12/22/2009	CA2434813C Imidazole derivatives
12/22/2009	CA2418538C Antibacterial mutilins
12/22/2009	CA2416527C Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
12/22/2009	CA2415386C Adhesive blends comprising hydrophilic and hydrophobic pressure sensitive adhesives
12/22/2009	CA2395987C Improved pharmaceutical formulations
12/22/2009	CA2373909C Multilayer drug form release in the colon
12/22/2009	CA2354024C A recombinant vector expressing multiple costimulatory molecules and uses thereof
12/22/2009	CA2346563C Novel 2-[3-phenyl-2-propenyl]-1,2,3,4-tetrahydroxyisoquinoline derivatives, preparation method and use as fungicides
12/22/2009	CA2345231C Pharmaceutical compositions comprising derivatives of sulphur acids
12/22/2009	CA2343325C Topical dermal antimicrobial compositions
12/22/2009	CA2322327C Treatment of viral disease in swine
12/22/2009	CA2305803C Crystalline antifungal polymorph
12/22/2009	CA2234565C Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers
12/22/2009	CA2205022C Adjuvant for a vaccine composition
12/22/2009	CA2181862C Mild newcastle disease virus vaccine
12/22/2009	CA2114221C 1, 3-oxathiolane nucleoside analogues
12/20/2009	CA2637538A1 Dar 1 (dermal acne remover)
12/19/2009	CA2633246A1 Identification of therapeutic agents for hiv infection
12/17/2009	WO2009152200A1 Tricyclic indole derivatives and methods of use thereof
12/17/2009	WO2009152189A1 Low dose topiramate/phentermine compostion and methods of use thereof
12/17/2009	WO2009151646A2 Non-invasive diagnostic agents and methods of diagnosing infectious disease
12/17/2009	WO2009151621A1 Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists
12/17/2009	WO2009151496A2 Induction of proliferation, effector molecule expression, and cytolytic capacity of hiv-specific cd8+ t cells
12/17/2009	WO2009151391A1 Controlled activation of the reuterin-production machinery of lactobacillus reuteri
12/17/2009	WO2009151313A1 A novel antiviral peptide against avian influenza virus h9n2
12/17/2009	WO2009151020A1 Novel fermented milk product and use thereof
12/17/2009	WO2009150281A1 Use of lauryl gallate in the prevention and treatment of infections caused by african swine fever virus (asfv)
12/17/2009	WO2009150194A1 Telaprevir dosing regimen
12/17/2009	WO2009149554A1 Antimicrobial components of the mucus and extruded slime of hagfish (myxine glutinosa)
12/17/2009	WO2009128963A3 Cross-neutralizing human monoclonal antibodies to sars-cov and methods of use thereof
12/17/2009	WO2009109532A3 Use of defensins against tuberculosis
12/17/2009	WO2009106714A3 Self-emulsifiable liquid florfenicol composition intended to be incorporated into the drinking water of livestock animals
12/17/2009	WO2009061491A3 Type iii secretion inhibitors and uses thereof
12/17/2009	WO2009046834A3 Use of t140 and optionally retrocyclin-1 as therapeutic agents for the treatment of m. tuberculosis infections
12/17/2009	WO2009043481A3 Use of adrenomedullin 13-52 and optionally retrocyclin-1 as a therapeutic agent for the treatment of hcmv infections
12/17/2009	WO2009043439A3 Use of retrocyclin- 1 as a therapeutic agent for the treatment of hcmv infections
12/17/2009	WO2009043437A3 Use of t140 and optionally retrocyclin-1 as therapeutic agents for the treatment of m. tuberculosis infections
12/17/2009	WO2009040072A3 Use of angiotensin i as a therapeutic agent in the treatment of eg aids or tuberculosis
12/17/2009	WO2009040071A3 Use of cyclo-rgdfv and optionally angiotensin i as therapeutic agents in the treatment of eg aids or tuberculosis
12/17/2009	WO2009040029A3 Use of adrenomedullin as a therapeutic agent for the treatment of excessive angiogenesis
12/17/2009	WO2009040028A3 Use of casoxin c and optionally adrenomedullin as therapeutic agents for the treatment of excessive angiogenesis
12/17/2009	WO2009039968A3 Use of angiotensin iii as a therapeutic agent in the treatment of eg hbv infection
12/17/2009	WO2009039966A3 Use of nf-kappab inhibitor sn50 and optionally angiotensin iii as therapeutic agents in the treatment of eg hbv infection
12/17/2009	WO2009039957A3 Use of angiotensin ii as a therapeutic agent in the treatment of eg s. pneumoniae infection
12/17/2009	WO2009033796A8 Use of a peptide as a therapeutic agent
12/17/2009	WO2009033707A3 Use of retrocyclin-1 as a therapeutic agent for the treatment of hcmv infections
12/17/2009	WO2009033661A3 Use of rgdspasskp and optionally angiotensin ii as therapeutic agents in the treatment of eg s. pneumoniae infections
12/17/2009	WO2008129308A3 Drug combination of beta 2 agonist and a progestin for the treatment of muscle loss
12/17/2009	US20090312543 Pyrazole compounds useful as protein kinase inhibitors
12/17/2009	US20090312406 Coumarin compounds and their use for treating viral infection
12/17/2009	US20090312352 Compositions and methods for treatment of disease caused by yersinia spp infection
12/17/2009	US20090312291 Agent for preventing infection
12/17/2009	US20090312249 TLR4 decoy receptor protein
12/17/2009	US20090312244 Compounds and methods for immunotherapy and diagnosis of tuberculosis
12/17/2009	US20090312241 Macrocyclic Compounds as Antiviral Agents
12/17/2009	US20090311746 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
12/17/2009	US20090311339 Antiviral preparation
12/17/2009	US20090311325 Enhancing solubility and dissolution rate of poorly soluble drugs
12/17/2009	US20090311305 Vaginal therapeutic device including copper metal and method of treating the vaginal using the vaginal therapeutic device
12/17/2009	US20090311290 Urogenital or anorectal transmucosal vaccine delivery system
12/17/2009	US20090311285 Vaccine
12/17/2009	US20090311218 Novel mutant interferon-alpha protein, particularly interferon-alpha subtype alpha 8; provides agents for susceptive diseases superior in anti-viral and anti-tumor actions compared with conventional agents for susceptive diseases; agents against tumors, viral diseases, and infection diseases

1 ... 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 ... 1798